Health Canada has updated the Johnson & Johnson COVID-19 vaccine product label to include the “very rare” side effect of thrombosis, or blood clotting, following vaccination.

canadiansathApril 27, 20211min2950

Health Canada has updated the Johnson & Johnson COVID-19 vaccine product label to include the “very rare” side effect of thrombosis, or blood clotting, following vaccination.
Canada’s regulatory body has determined that the benefits of the one-shot vaccine outweigh the risks of thrombosis.

Leave a Reply

Your email address will not be published. Required fields are marked *